AYTU

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Aytu BioScience Inc

NASDAQ | AYTU

2.09

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 14, 2025)

$20.99M

Market Cap

-

P/E Ratio

-2.26

EPS

$2.82

52 Week High

$0.95

52 Week Low

HEALTHCARE

Sector

AYTU Chart

Recent Chart
Price Action

AYTU Technicals

Tags:

AYTU Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit $46M
Total Revenue $66M
Cost Of Revenue $21M
Costof Goods And Services Sold $21M
Operating Income -$7.8M
Selling General And Administrative $17M
Research And Development $1.3M
Operating Expenses $40M
Investment Income Net -
Net Interest Income -$3.7M
Interest Income -
Interest Expense $3.7M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.4M
Income Before Tax -$14M
Income Tax Expense $437K
Interest And Debt Expense -
Net Income From Continuing Operations -$14M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$4.7M
Net Income -$14M

Revenue & Profitability

Earnings Performance

AYTU Financials

yearly Balance Sheet (As of Jun 30, 2025)

Field Value (USD)
Total Assets $124M
Total Current Assets $79M
Cash And Cash Equivalents At Carrying Value $31M
Cash And Short Term Investments $31M
Inventory $11M
Current Net Receivables $31M
Total Non Current Assets $45M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $42M
Intangible Assets Excluding Goodwill $42M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $5.6M
Other Non Current Assets -
Total Liabilities $105M
Total Current Liabilities $63M
Current Accounts Payable $11M
Deferred Revenue -
Current Debt -
Short Term Debt $1.9M
Total Non Current Liabilities $42M
Capital Lease Obligations -
Long Term Debt $11M
Current Long Term Debt $11M
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.9M
Other Current Liabilities $51M
Other Non Current Liabilities $4.9M
Total Shareholder Equity $19M
Treasury Stock -
Retained Earnings -$334M
Common Stock $1K
Common Stock Shares Outstanding $6.3M

yearly Cash Flow (As of Jun 30, 2025)

Field Value (USD)
Operating Cashflow -$1.9M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $5.4M
Capital Expenditures $228K
Change In Receivables -
Change In Inventory $382K
Profit Loss -
Cashflow From Investment -$2.6M
Cashflow From Financing $15M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$14M

yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit $46M
Total Revenue $66M
Cost Of Revenue $21M
Costof Goods And Services Sold $21M
Operating Income -$7.8M
Selling General And Administrative $17M
Research And Development $1.3M
Operating Expenses $40M
Investment Income Net -
Net Interest Income -$3.7M
Interest Income -
Interest Expense $3.7M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.4M
Income Before Tax -$14M
Income Tax Expense $437K
Interest And Debt Expense -
Net Income From Continuing Operations -$14M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$4.7M
Net Income -$14M

AYTU News

AYTU Profile

Aytu BioScience Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Aytu BioScience Inc. is a forward-looking specialty pharmaceutical company based in Englewood, Colorado, dedicated to improving healthcare outcomes through the development of innovative therapeutics. The company’s diverse portfolio targets significant unmet medical needs related to hypogonadism, respiratory ailments, insomnia, and male infertility, catering to both domestic and international markets. By strategically focusing on niche segments, Aytu aims to deliver unique pharmaceutical solutions that enhance patient quality of life while driving sustainable growth and positioning itself as a key player in the healthcare industry.

WTO
+19.50%
$0.02
LPTX
+368.57%
$2.05
ASBP
+1.04%
$0.10
VINE
+1.80%
$0.40
AMZE
+1.80%
$0.40
EPWK
+16.62%
$0.04
VHAI
+33.33%
$0.00
NVDA
+1.77%
$190.17
ONDS
+9.45%
$7.18
IVVD
+32.76%
$2.35
BYND
+6.93%
$1.08
ASST
-6.08%
$1.08
CHR
+1.67%
$0.04
TSLA
+0.58%
$404.35
PFE
-2.83%
$25.06
SOFI
-2.00%
$27.82
PLUG
-9.83%
$2.24
BITF
-0.76%
$2.58
ACHR
-1.00%
$7.88
NVVE
-45.37%
$0.25
ETHD
+1.75%
$5.23
INTC
-1.08%
$35.52
F
-0.67%
$13.19
RGTI
+1.11%
$25.48
AXDX
-61.36%
$0.03
PLTR
+1.08%
$174.01
RIVN
-7.80%
$15.11
TLRY
-4.42%
$1.08
CIFR
-3.81%
$14.36
SNAP
-0.11%
$8.57
WULF
-5.90%
$10.99
NIO
-1.28%
$6.16
WBD
+4.01%
$23.03
CRWV
-1.25%
$77.36
QBTS
+0.94%
$23.61
ADAP
-15.14%
$0.05
IONZ
-8.28%
$5.20
DNN
-0.40%
$2.48
BMNR
-5.93%
$34.40
MARA
-6.18%
$11.99
IREN
-4.68%
$46.37
DVLT
+18.83%
$1.83
AAPL
-0.19%
$272.41
AMD
-0.46%
$246.81
MKDW
-18.20%
$0.16
APLD
+2.55%
$23.65
APLT
-19.14%
$0.21
CLSK
-8.51%
$10.96
CAN
-8.04%
$0.89
RMBL
+60.50%
$3.21
GRAB
-2.34%
$5.41
LNW
-3.71%
$86.22
CSCO
+0.80%
$78.00
AMZN
-1.21%
$234.69
ADD
-25.47%
$0.05
CRCL
-0.54%
$81.89
T
-0.62%
$25.59
SMCI
+3.79%
$36.42
MU
+4.16%
$246.83
ORCL
+2.42%
$222.85
BTG
0.00%
$4.10
SRM
+53.27%
$10.30
QUBT
+5.68%
$10.60
KVUE
-0.65%
$16.66
BABA
-3.77%
$153.80
AAL
-2.37%
$12.76
BBD
+0.54%
$3.68
BAC
-0.49%
$52.61
HOOD
+0.79%
$122.50
NBIS
-5.74%
$83.54
RIOT
+0.50%
$13.95
HIMS
+2.57%
$36.98
RXRX
-4.38%
$4.14
NOK
-0.73%
$6.73
JD
-4.55%
$29.31
DFLI
+4.85%
$0.81
PLTZ
-2.27%
$6.88
GPUS
-7.60%
$0.27
PLTD
-1.01%
$6.84
GOOGL
-0.77%
$276.41
HPE
-0.43%
$22.83
QS
-1.03%
$13.43
BTBT
-4.36%
$2.41
RIG
0.00%
$4.01
VZ
-0.12%
$41.06
IONQ
+3.92%
$47.18
WLGS
-5.57%
$0.04
MSFT
+1.36%
$510.18
SOUN
-0.40%
$12.17
MTSR
-0.35%
$70.50
XPON
-8.66%
$1.16
XPEV
-5.19%
$25.01
ABEV
+1.19%
$2.55
BTE
+0.63%
$3.16
SMR
-3.02%
$22.45
BURU
-2.77%
$0.24
DEFT
-15.17%
$1.23
RGTZ
-2.55%
$27.42
EOSE
-9.24%
$13.80
VALE
-0.64%
$12.30
WTO
+19.50%
$0.02
LPTX
+368.57%
$2.05
ASBP
+1.04%
$0.10
VINE
+1.80%
$0.40
AMZE
+1.80%
$0.40
EPWK
+16.62%
$0.04
VHAI
+33.33%
$0.00
NVDA
+1.77%
$190.17
ONDS
+9.45%
$7.18
IVVD
+32.76%
$2.35
BYND
+6.93%
$1.08
ASST
-6.08%
$1.08
CHR
+1.67%
$0.04
TSLA
+0.58%
$404.35
PFE
-2.83%
$25.06
SOFI
-2.00%
$27.82
PLUG
-9.83%
$2.24
BITF
-0.76%
$2.58
ACHR
-1.00%
$7.88
NVVE
-45.37%
$0.25
ETHD
+1.75%
$5.23
INTC
-1.08%
$35.52
F
-0.67%
$13.19
RGTI
+1.11%
$25.48
AXDX
-61.36%
$0.03
PLTR
+1.08%
$174.01
RIVN
-7.80%
$15.11
TLRY
-4.42%
$1.08
CIFR
-3.81%
$14.36
SNAP
-0.11%
$8.57
WULF
-5.90%
$10.99
NIO
-1.28%
$6.16
WBD
+4.01%
$23.03
CRWV
-1.25%
$77.36
QBTS
+0.94%
$23.61
ADAP
-15.14%
$0.05
IONZ
-8.28%
$5.20
DNN
-0.40%
$2.48
BMNR
-5.93%
$34.40
MARA
-6.18%
$11.99
IREN
-4.68%
$46.37
DVLT
+18.83%
$1.83
AAPL
-0.19%
$272.41
AMD
-0.46%
$246.81
MKDW
-18.20%
$0.16
APLD
+2.55%
$23.65
APLT
-19.14%
$0.21
CLSK
-8.51%
$10.96
CAN
-8.04%
$0.89
RMBL
+60.50%
$3.21
GRAB
-2.34%
$5.41
LNW
-3.71%
$86.22
CSCO
+0.80%
$78.00
AMZN
-1.21%
$234.69
ADD
-25.47%
$0.05
CRCL
-0.54%
$81.89
T
-0.62%
$25.59
SMCI
+3.79%
$36.42
MU
+4.16%
$246.83
ORCL
+2.42%
$222.85
BTG
0.00%
$4.10
SRM
+53.27%
$10.30
QUBT
+5.68%
$10.60
KVUE
-0.65%
$16.66
BABA
-3.77%
$153.80
AAL
-2.37%
$12.76
BBD
+0.54%
$3.68
BAC
-0.49%
$52.61
HOOD
+0.79%
$122.50
NBIS
-5.74%
$83.54
RIOT
+0.50%
$13.95
HIMS
+2.57%
$36.98
RXRX
-4.38%
$4.14
NOK
-0.73%
$6.73
JD
-4.55%
$29.31
DFLI
+4.85%
$0.81
PLTZ
-2.27%
$6.88
GPUS
-7.60%
$0.27
PLTD
-1.01%
$6.84
GOOGL
-0.77%
$276.41
HPE
-0.43%
$22.83
QS
-1.03%
$13.43
BTBT
-4.36%
$2.41
RIG
0.00%
$4.01
VZ
-0.12%
$41.06
IONQ
+3.92%
$47.18
WLGS
-5.57%
$0.04
MSFT
+1.36%
$510.18
SOUN
-0.40%
$12.17
MTSR
-0.35%
$70.50
XPON
-8.66%
$1.16
XPEV
-5.19%
$25.01
ABEV
+1.19%
$2.55
BTE
+0.63%
$3.16
SMR
-3.02%
$22.45
BURU
-2.77%
$0.24
DEFT
-15.17%
$1.23
RGTZ
-2.55%
$27.42
EOSE
-9.24%
$13.80
VALE
-0.64%
$12.30
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.